The application development software provider has closed its initial public offering, with Zoom and Salesforce having bought $150m of shares.

The Alibaba and Groupe Artémis-backed upmarket goods marketplace issued 5.75 million shares priced at $20 each.

The SoftBank-backed online tutoring course provider has floated in a $41.7m offering that comes in the wake of some $1.1bn in venture funding.

Salesforce Ventures and Zoom are each buying $75m of shares in a private placement alongside the work management platform developer's flotation.

The Mastercard, Visa, CreditEase and CommerzBank-backed card issuing platform developer priced the offering above its range.

The oncology therapy developer has filed for an IPO just two years after emerging from stealth to advance Harvard and Stanford research.

Centessa, formed earlier this year through a ten-way merger involving multiple spinouts, has completed a listing in the US.

JD.com has followed up the December flotation of its JD Health spinoff by listing its Tencent and China Life-backed logistics vehicle.

Access Industries and Takeda scored exits as the oncology therapy developer floated at the top of its range in an upsized offering.

UC San Francisco spinout Effector Therapeutics is set to go public through a reverse merger with Locust Walk Acquisition Corp that includes a $60m PIPE financing.